Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Drug Targets|August 25, 2021
Targeting Triglyceride Metabolism for Colorectal Cancer Prevention and TherapyNagendra Yarla, Venkateshwar Madka, Chinthalapally RaoBiorxiv : the Preprint Server for Biology|May 10, 2023
A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progressionMichael P Plebanek, Yue Xue, Y-Van Nguyen, et al.Biorxiv : the Preprint Server for Biology|April 15, 2024
Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin SignalingNicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, et al.Cancer Research|February 19, 2025
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin SignalingNicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, et al.Science Translational Medicine|November 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapyBalamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I ExpressionBala Theivanthiran, Nagendra Yarla, Kaylee Villareal, et al.Pageof 1